SEC charges MiMedx Group with accounting fraud

/web/img/field/image/sec_0.jpg

Biotech company MiMedx Group and three of its former top executives have been charged with defrauding investors. In response, MiMedx reshuffled its management team, including the appointment of a new general counsel and secretary.

THIS IS MEMBERS-ONLY CONTENT

Already a Member? SIGN IN here. If you’re not, click HERE for more information on our 30-day free trials and why you’re not able to view this story.